NRXS Competitors & Alternatives
Compare Neuraxis, Inc. with similar stocks in the same industry
Biotechnology
NRXS
Main Stock$7.11
Tradestie Score
33
Market Cap
$30.70M
Revenue Growth
1.2%
Analyst Upside
+54.7%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.99
|
$170.45M | - | 59 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$7.24
|
$158.43M | - | 44 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.92
|
$154.27M | - | 68 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.94
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.73
|
$114.01M | - | 44 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.80
|
$110.20M | - | 61 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.86
|
$84.52M | - | 59 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.68
|
$67.94M | - | 45 | Compare |
|
XLO
Xilio Therapeutics, Inc. Common Stock
|
$9.01
|
$43.15M | - | 59 | Compare |
|
SHFS
SHF Holdings, Inc. Class A Common Stock
|
$1.18
|
$21.61M | - | 36 | Compare |
More NRXS Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 3845)
232 stocks in this industry